ARCHIVES

New Community Control Program May Be Developed

This article is from The Cancer Letter archive.

Vol. 01 No. 43 | October 24, 1975

Download PDF Visit The Full Archive

Related Articles

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

ASCO Lists Top 11 Advances In Clinical Cancer Research

December 30, 2005

NIH RPG Success Rate to Fall Further

June 7, 2013

FDA Advisory Panel Unanimously Favors New Stool DNA Colorectal Screening Test

March 28, 2014

Pharmacia Letter Announces Suspension Of Two Trials.

May 11, 2001

NCAB Member Pollin Organizes Minority Outreach Effort

January 4, 1991